Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients
- 4 January 2006
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 27 (2) , 155-162
- https://doi.org/10.1002/humu.20281
Abstract
Periocular sebaceous gland carcinomas (SGCs) occur in the eyelids either sporadically or as a phenotypic feature of Muir-Torre syndrome (MTS). In knockout mice mismatch-repair (MMR) defects or inactivation of the fragile histidine triad (FHIT) gene are associated with MTS-like signs, including SGC. To dissect the genetic alterations associated with microsatellite instability (MSI) and inactivation of the FHIT gene, we studied nine periocular SGC specimens from MTS patients. Immunohistochemistry was performed for FHIT, MSH2, MLH1, and MSH6. We assessed MSI as well as loss of heterozygosity (LOH) at the FHIT locus with polymorphic markers and genomic multiplex PCR. Epigenetic silencing was detected by methylation-specific PCR (MSP) and combined bisulfite restriction analysis (COBRA). Our analyses identified two SGCs with FHIT positivity and high-grade MSI, and seven cases with loss of FHIT and microsatellite stability (MSS). MSI correlated with loss of MSH2 and MLH1 immunostaining. Loss-of-function mechanisms affecting the FHIT gene were identified as intragenic deletions eliminating the coding exons 5 and 6 on one hand, and complete biallelic methylation of the FHIT transcription regulatory region on the other hand. Germinal FHIT mutations as a predisposing factor for MTS were excluded in two index patients with cancer in three generations, including an FHIT-negative SGC. Our data suggest that either somatic inactivation of the FHIT gene associated with MSS or inactivation of the MMR system resulting in MSI contribute to the development of periocular SGCs in presumptive MTS. Hum Mutat 27(2), 155–162, 2006.Keywords
This publication has 32 references indexed in Scilit:
- Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomasLiver International, 2005
- Components of DNA Damage Checkpoint Pathway Regulate UV Exposure–Dependent Alterations of Gene Expression of FHIT and WWOX at Chromosome Fragile SitesMolecular Cancer Research, 2005
- Involvement of the Fhit gene in the ionizing radiation‐activated ATR/CHK1 pathwayJournal of Cellular Physiology, 2004
- BRCA1 Is Required for Common-Fragile-Site Stability via Its G2/M Checkpoint FunctionMolecular and Cellular Biology, 2004
- ATR Regulates Fragile Site StabilityCell, 2002
- Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9Biochemical Journal, 2000
- Muir-Torre Phenotype Has a Frequency of DNA Mismatch-Repair-Gene Mutations Similar to That in Hereditary Nonpolyposis Colorectal Cancer Families Defined by the Amsterdam CriteriaAmerican Journal of Human Genetics, 1998
- The Muir-Torre syndrome: A 25-year retrospectJournal of the American Academy of Dermatology, 1995
- Muir-Torre syndrome: a variant of the cancer family syndrome.Journal of Medical Genetics, 1994
- Hyperplasies sébacées, kérato-acanthomes, épithéliomas du visage et cancer du colonDermatology, 1976